While numerous business have been called out by the FDA for promoting CBD as a way to prevent or cure COVID-19, research suggests it may benefit certain patients under medical supervision.
WeedWeek
- A pre-clinical study found CBD, and potentially other cannabinoids, added to anti-viral therapies may reduce the lung inflammation associated with some severe cases.
Science Direct
Quick Hits
- An alumnus gave MIT and Harvard Medical School $9M to study how MED affects the brain and behavior.
The Harvard Gazette - Leafly rounds up products containing CBG, CBN and other rare cannabinoids.
